Table 2.
Baseline serum 25(OH)D and markers of inflammation and immunity by treatment1
| Placebo (n = 24) | Vitamin D (n = 22) | |
|---|---|---|
| 25(OH)D (ng/ml) | 32 ± 92 | 27 ± 7 |
| TNF-α (pg/ml) | 54.0 (50.1, 59.8) | 54.5 (50.5, 68.6) |
| IL-6 (pg/ml) | 39.0 (37.5, 43.5)3 | 40.8 (38.6, 44.8)5 |
| NGAL (ng/ml) | 27.0 ± 5.8 | 24.83 ± 5.5 |
| MCP-1 (pg/ml) | 61.5 ± 8.74 | 68.1 ± 16.7 |
| IP-10 (pg/ml) | 97.2 (78.4, 118.8) | 102.3 (78.7, 135.3) |
| LL-37 (ng/ml) | 45.5 (41.1, 54.1) | 44.3 (37.4, 55.4)5 |
1
Values reported as median (IQR) or mean (±SD). Abbreviations: 25(OH)D, 25-hydroxyvitamin D; TNF-α, tumor necrosis factor-α; IL-6, interleukin-6; NGAL, neutrophil gelatinase-associated lipocalin; MCP-1, monocyte chemoattractant protein-1; IP-10, interferon gamma-induced protein-10; LL-37, cathelicidin.
2
P for group difference = 0.03
3
n = 23,
4
n = 21,
5
n = 20